Company / Current Assets per Share
CRISPR Therapeutics AG Current Assets per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets per Share
$20.71
FY2025
5-year range
$20.71 / $31.40
FY2021-FY2025
Trend
-8.3%
vs FY2024
Sector context
#28 of 210
Health Care
What the data says
CRISPR Therapeutics AG's current assets per share of $20.71 is higher than 87% of companies in the Health Care sector (FY2025). Current Assets per Share has fluctuated over the past 10 years, ranging from $6.25 in FY2017 to $57.92 in FY2016.
Based on SEC 10-K filings.
20.71 in FY2025 with a 5-year CAGR of -2.3%. Top quartile in the Health Care sector.
Declined from $23.84 to $20.71 over the past 2 years.
Health Care sector context is included.
Current Assets per Share over time
Growth rates
- 3-Year CAGR
- -4.3%
- 5-Year CAGR
- -2.3%
- 10-Year CAGR
- -
Sector benchmark
-87.9% below sector average
Key checks
Key Insights
- In FY2025, current assets per share decreased 8.3% year-over-year.
- Ranks #28 out of 210 companies in the Health Care sector.
- Peak current assets per share was recorded in FY2016.
- Lowest current assets per share in the period was in FY2017.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current Assets per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $20.71 | -8.3% |
| FY2024 | $22.59 | -5.2% |
| FY2023 | $23.84 | +1.0% |
| FY2022 | $23.60 | -24.8% |
| FY2021 | $31.40 | +35.2% |
| FY2020 | $23.22 | +21.9% |
| FY2019 | $19.05 | +65.8% |
| FY2018 | $11.49 | +83.7% |
| FY2017 | $6.25 | -89.2% |
| FY2016 | $57.92 | +86.0% |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026